In an 85-year-old patient with a left ventricular ejection fraction of 44% and atrial fibrillation, what is the appropriate management?

Management of AF with EF 44% in an 85-Year-Old Patient

In an 85-year-old patient with atrial fibrillation and an ejection fraction of 44%, you must initiate oral anticoagulation (preferably a DOAC over warfarin) and implement rate control with a beta-blocker or digoxin, while considering rhythm control strategies if symptoms persist despite adequate rate control.

Anticoagulation: The Non-Negotiable Priority

This patient requires anticoagulation regardless of other factors. At age 85 with AF, the stroke risk is substantial—age alone confers significant thromboembolic risk 1.

Specific Anticoagulation Approach:

• First choice: Direct oral anticoagulants (DOACs)—apixaban, dabigatran, edoxaban, or rivaroxaban—are preferred over warfarin 2
• If using warfarin: Target INR 2.0-3.0, though some experts recommend a lower target of 1.6-2.5 in patients ≥75 years to minimize bleeding risk 3, 1
• Critical caveat: Assess renal function before DOAC selection, as all are partially renally excreted. If creatinine clearance <30 mL/min, dabigatran is contraindicated; rivaroxaban requires dose adjustment 4
• Avoid aspirin monotherapy: This patient is not low-risk and requires full anticoagulation 5, 1

The CHA₂DS₂-VASc score guides this decision: age 85 = 2 points, making the score ≥2 even without other risk factors, mandating anticoagulation 2.

Rate Control Strategy

With an EF of 44% (borderline reduced ejection fraction), rate control is essential and should be approached cautiously:

Initial Rate Control Options:

1. Beta-blockers: First-line choice for rate control at rest and during exercise 6, 7
2. Digoxin: Effective for resting heart rate control, particularly useful in this patient with borderline reduced EF 6, 7
3. Combination therapy: Digoxin plus beta-blocker is reasonable if monotherapy inadequately controls rate 6, 7

What to Avoid:

• Nondihydropyridine calcium channel blockers (diltiazem, verapamil): Use with extreme caution or avoid entirely given the EF of 44%. These are recommended only for HF with preserved EF (>40%), and this patient is at the threshold 6, 7
• Intravenous calcium channel blockers: Absolutely contraindicated if any signs of decompensation 7

Target Heart Rate:

• Resting heart rate: <80-100 bpm
• Exercise heart rate: Adjust medications to keep rate in physiological range during activity 6
• Monitor during exercise: Assess heart rate control during physical activity and adjust therapy accordingly 6, 7

Rhythm Control Consideration

Given the borderline reduced EF (44%), rhythm control deserves serious consideration:

When to Pursue Rhythm Control:

• If symptoms persist despite adequate rate control 6, 7
• If tachycardia-induced cardiomyopathy is suspected (the AF may be causing or worsening the reduced EF) 6, 7
• Early rhythm control may reduce morbidity and mortality in selected patients 2

Rhythm Control Options:

1. Catheter ablation: Increasingly favored as first-line or second-line therapy, even in elderly patients. Recent evidence shows catheter ablation improves outcomes in HF with reduced EF 8, 9. Age alone should not preclude ablation 10
2. Amiodarone: Most appropriate antiarrhythmic drug for this patient with borderline reduced EF, as other agents (sotalol, propafenone, flecainide) are contraindicated or less safe 6
3. AV node ablation with pacing: Consider if pharmacological rate control fails and symptoms persist 6, 7

Critical Safety Point:

• Anticoagulation must continue for at least 3 weeks before any cardioversion attempt if AF duration >24 hours 2
• Anticoagulation continues indefinitely regardless of whether sinus rhythm is maintained, based on stroke risk 2

Monitoring and Follow-Up

Essential Assessments:

• Renal function: Check creatinine clearance before starting DOACs and monitor periodically (at least annually, more frequently if borderline) 4
• INR monitoring if on warfarin: Weekly during initiation, then monthly when stable 1
• Heart rate assessment: Both resting and during exercise 6, 7
• Echocardiographic follow-up: Reassess EF after rate/rhythm control optimization to determine if cardiomyopathy was tachycardia-induced 6

Common Pitfalls to Avoid

1. Withholding anticoagulation due to age: Age 85 is not a contraindication; bleeding risk is lower than stroke risk in untreated AF 3
2. Using calcium channel blockers with borderline EF: Can precipitate decompensation 7
3. Inadequate rate control assessment: Must check heart rate during activity, not just at rest 6
4. Stopping anticoagulation after successful cardioversion: Stroke risk persists regardless of rhythm 2
5. Assuming rhythm control is too risky in elderly: Catheter ablation can be safe and effective even in octogenarians 10

Practical Algorithm

Step 1: Start DOAC immediately (check renal function first)
Step 2: Initiate beta-blocker for rate control
Step 3: Add digoxin if beta-blocker alone insufficient
Step 4: Assess symptoms after 4-6 weeks of adequate rate control
Step 5: If symptomatic despite rate control OR if EF worsens, pursue rhythm control (consider catheter ablation or amiodarone)
Step 6: Reassess EF after 3-6 months of optimized therapy

6, 1, 7, 2, 9